Make Way for Chinese Ozempic

The Signal Daily

Jun 7 2024 • 8 mins

Danish Novo Nordisk’s patent on semaglutide — the active ingredient in weight loss drug Ozempic expires in 2026. In the meantime, Chinese firms have been hard at work, trying to develop at least 15 generic versions of Ozempic and Wegovy.  What does that mean for the pharmaceutical market?

In other news, a crisis is brewing at VIP industries as amid declining profits, Nisaba Godrej resigned as an independent director on the board of VIP Industries. What's happening to the legacy suitcase company VIP? Tune in!

You Might Like

The Daily
The Daily
The New York Times
The Dan Bongino Show
The Dan Bongino Show
Cumulus Podcast Network | Dan Bongino
WSJ What’s News
WSJ What’s News
The Wall Street Journal
Pod Save America
Pod Save America
Crooked Media
The Ben Shapiro Show
The Ben Shapiro Show
The Daily Wire
Mark Levin Podcast
Mark Levin Podcast
Cumulus Podcast Network
The Glenn Beck Program
The Glenn Beck Program
Blaze Podcast Network
Morning Joe
Morning Joe
Joe Scarborough and Mika Brzezinski, MSNBC
The Fox News Rundown
The Fox News Rundown
FOX News Radio
The Rachel Maddow Show
The Rachel Maddow Show
Rachel Maddow, MSNBC
Morning Wire
Morning Wire
The Daily Wire
Start Here
Start Here
ABC News
FiveThirtyEight Politics
FiveThirtyEight Politics
ABC News, 538, FiveThirtyEight, Galen Druke
The Matt Walsh Show
The Matt Walsh Show
The Daily Wire